Mechanisms of pharmacokinetic interaction between propranolol and quinidine in rats.
In order to study the mechanism of propranolol-quinidine interaction, the effects of quinidine on propranolol pharmacokinetics were examined in male Wistar rats. The concurrent oral administration of quinidine (10 mg/kg) markedly increased the plasma concentration of propranolol (2.5 mg/kg), and the area under the propranolol concentration-time curve increased about 3.6-fold. These results are consistent with previous observations in man and indicate the possible usefulness of the male Wistar rat as an animal model for investigating the mechanisms of the drug interaction. When propranolol was given intravenously, a concurrent administration of quinidine increased the apparent distribution volume of propranolol, mainly by decreasing its plasma protein binding. However, the systemic clearance of propranolol was not significantly altered by quinidine. Thus, quinidine increased the availability of oral propranolol from 13.8 +/- 2.2 to 44.2 +/- 4.6% (p less than 0.01). Furthermore, quinidine delayed the elimination of propranolol from the isolated perfused rat liver. These results indicate that quinidine reduces the presystemic elimination of propranolol in the liver, thereby increasing its systemic availability after oral administration.
Yamada
K
K
Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Japan.
Yasuhara
M
M
Yatsuzuka
A
A
Okumura
K
K
Sakurai
T
T
Kawai
C
C
Hori
R
R
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D011433:Propranolol / Q000493:pharmacokinetics*; D011485:Protein Binding; D011802:Quinidine / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
D001798:Blood Proteins; D011433:Propranolol; D011802:Quinidine